← back to search

P. Fumoleau

Université Claude Bernard Lyon 1 · FR
Area of research
Oncology · Cancer Research
Research interest
Research interests include Medicine, Oncology, Breast cancer, Biology, Cervical cancer, and Aflibercept.
h-index
citations
696
works
7
NIH funding
primary concept
email

Recent publications

Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site
British Journal of Cancer 2020cited by 88position: middledoi
Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome
EBioMedicine 2019cited by 51position: middledoi
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers
Nature Communications 2016cited by 158position: middledoi
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
Annals of Oncology 2014cited by 202position: middledoi
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial
The Lancet Oncology 2012cited by 131position: middledoi
Phase I Dose-Escalation Study of Intravenous Aflibercept in Combination with Docetaxel in Patients with Advanced Solid Tumors
Clinical Cancer Research 2012cited by 44position: middledoi
Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours
British Journal of Cancer 2012cited by 22position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Sylvie Zanetta · Klinikum Stuttgart2 papers (2012–2012)Karen Soussan-Lazard · Université Claude Bernard Lyon 12 papers (2012–2012)Benoît You · Communauté urbaine de Lyon2 papers (2012–2012)Claire Falandry · Institute of Aging2 papers (2012–2012)Nicolás Isambert · Université de Poitiers2 papers (2012–2012)Samira Ziti‐Ljajic · Université Claude Bernard Lyon 12 papers (2012–2012)Gilles Freyer · Eau de Paris (France)2 papers (2012–2012)Martine Piccart · Tecnológico de Monterrey2 papers (2012–2014)Laure Favier · Hôpital Européen Georges-Pompidou2 papers (2012–2012)V. Trillet-Lenoir · Université Claude Bernard Lyon 12 papers (2012–2012)Sylvie Assadourian · Université Claude Bernard Lyon 12 papers (2012–2012) · 1 papers (2014–2014)Beverly Moy · Harvard University1 papers (2012–2012)Paul E. Goss · Queen's University1 papers (2012–2012)Gursel Aktan · National Cancer Centre Japan1 papers (2012–2012)Bent Ejlertsen · University of Copenhagen1 papers (2012–2012)Gaëtan MacGrogan · MRC Cancer Unit1 papers (2014–2014)Kathleen I. Pritchard · Sunnybrook Health Science Centre1 papers (2012–2012)Khalil Zaman · Breast Center1 papers (2014–2014)Hervé Bonnefoi · Sonnenhalde (Switzerland)1 papers (2014–2014)